Julien Verrax

6.0k citations

53 papers · 5.0k indexed · 1 hit paper · h-index 34

Impact in

Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents

Papers in

Toxicology 12
- Bioactive Compounds and Antitumor Agents 12
Nutrition and Dietetics 26
- Vitamin C and Antioxidants Research 24

Co-authors: Pedro Buc Calderón Olivier Féron Bernard Gallez Pierre Sonveaux Christophe J. De Saedeleer Brice Sid Christophe Glorieux Mark W. Dewhirst
Journals: Biochemical Pharmacology (9 papers)Free Radical Biology and Medicine (5 papers)PLoS ONE (5 papers)Biochemical and Biophysical Research Communications (4 papers)European Journal of Medicinal Chemistry (2 papers)
Partner nations: Belgium Chile Brazil

In The Last Decade

Julien Verrax

52 papers receiving 4.9k citations

Hit Papers

align trajectories log scale

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice 2008 · 1.3k citations

Peers

Countries citing papers authored by Julien Verrax

Since Specialization

Citations

This map shows the geographic impact of Julien Verrax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Verrax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Verrax more than expected).

Fields of papers citing papers by Julien Verrax

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Verrax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Verrax. The network helps show where Julien Verrax may publish in the future.

Co-authors

The 25 scholars most cited alongside Julien Verrax, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Julien Verrax Line = papers co-authored together Julien Verrax links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Use of a cocktail of spin traps for fingerprinting large range of free radicals in biological systems PLoS ONE ·Valérie Marchand, Nicolas Charlier, Julien Verrax, Pedro Buc Calderón, Philippe Lévêque, Bernard Gallez	2017	14
2	Regulation of catalase expression in healthy and cancerous cells Free Radical Biology and Medicine ·Christophe Glorieux, Marcel Zámocký, Juan M. Sandoval, Julien Verrax, Pedro Buc Calderón	2015	207
3	Catalase expression in MCF-7 breast cancer cells is mainly controlled by PI3K/Akt/mTor signaling pathway Biochemical Pharmacology ·Christophe Glorieux, Julien Auquier, Nicolas Dejeans, Brice Sid, Jean‐Baptiste Demoulin, Luc Bertrand, Julien Verrax, Pedro Buc Calderón	2014	40
4	Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells British Journal of Cancer ·Manuel Valenzuela, Christophe Glorieux, Julie Stockis, Brice Sid, Juan M. Sandoval, Karina Bettega Felipe, Maicon Roberto Kviecinski, Julien Verrax, Pedro Buc Calderón	2014	56
5	Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells PLoS ONE ·Christophe J. De Saedeleer, Tamara Copetti, Paolo E. Porporato, Julien Verrax, Olivier Féron, Pierre Sonveaux	2012	207
6	Gut microbiota-derived propionate reduces cancer cell proliferation in the liver British Journal of Cancer ·Laure B. Bindels, Paolo E. Porporato, Evelyne Dewulf, Julien Verrax, Audrey M. Neyrinck, Jennifer C. Martin, Karen P. Scott, Pedro Buc Calderón, Olivier Féron, Giulio G. Muccioli, Pierre Sonveaux, Patrice D. Cani, Nathalie M. Delzenne	2012	229
7	Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis PLoS ONE ·Pierre Sonveaux, Tamara Copetti, Christophe J. De Saedeleer, Frédérique Végran, Julien Verrax, Kelly M. Kennedy, Eui Jung Moon, Suveera Dhup, Pierre Danhier, Françoise Frérart, Bernard Gallez, Anthony A. Ribeiro, Carine Michiels, Mark W. Dewhirst, Olivier Féron	2012	413
8	Redox-Active Quinones and Ascorbate: An Innovative Cancer Therapy That Exploits the Vulnerability of Cancer Cells to Oxidative Stress Anti-Cancer Agents in Medicinal Chemistry ·Julien Verrax, Raphaël Beck, Nicolas Dejeans, Christophe Glorieux, Brice Sid, Rozangela Curi Pedrosa, Julio Benites, David Vásquez, Jaime A. Valderrama, Pedro Buc Calderón	2011	57
9	Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy Biochemical Pharmacology ·Christophe Glorieux, Nicolas Dejeans, Brice Sid, Raphaël Beck, Pedro Buc Calderón, Julien Verrax	2011	122
10	Intracellular ATP levels determine cell death fate of cancer cells exposed to both standard and redox chemotherapeutic agents Biochemical Pharmacology ·Julien Verrax, Nicolas Dejeans, Brice Sid, Christophe Glorieux, Pedro Buc Calderón	2011	48
11	Molecular Chaperone Hsp90 as a Target for Oxidant-Based Anticancer Therapies Current Medicinal Chemistry ·Raphaël Beck, Nicolas Dejeans, Christophe Glorieux, R. C. Pedrosa, David Vásquez, Jaime A. Valderrama, Pedro Buc Calderón, Julien Verrax	2011	26
12	Biological evaluation of donor-acceptor aminonaphthoquinones as antitumor agents European Journal of Medicinal Chemistry ·Julio Benites, Jaime A. Valderrama, Karina F. Bettega, Rozangela Curi Pedrosa, Pedro Buc Calderón, Julien Verrax	2010	107
13	Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study Investigational New Drugs ·Raphaël Beck, Rozangela Curi Pedrosa, Nicolas Dejeans, Christophe Glorieux, Philippe Levêque, Bernard Gallez, Henryk Taper, Stéphane Eeckhoudt, Laurent Knoops, Pedro Buc Calderón, Julien Verrax	2010	56
14	Synthesis and antitumor evaluation of 8-phenylaminopyrimido[4,5-c]isoquinolinequinones Bioorganic & Medicinal Chemistry Letters ·David Vásquez, Jaime Rodrı́guez, Cristina Theoduloz, Julien Verrax, Pedro Buc Calderón, Jaime A. Valderrama	2009	14
15	In Situ Modulation of Oxidative Stress: A Novel and Efficient Strategy to Kill Cancer Cells Current Medicinal Chemistry ·Julien Verrax, R. C. Pedrosa, Raphaël Beck, Nicolas Dejeans, H Taper, Pedro Buc Calderón	2009	62
16	Endoplasmic reticulum calcium release potentiates the ER stress and cell death caused by an oxidative stress in MCF-7 cells Biochemical Pharmacology ·Nicolas Dejeans, Nicolas Tajeddine, Raphaël Beck, Julien Verrax, Henryk Taper, Philippe Gailly, Pedro Buc Calderón	2009	67
17	Targeting Cancer Cells by an Oxidant-Based Therapy Current Molecular Pharmacology ·Pedro Buc Calderón, Julien Verrax, H Taper	2008	24
18	Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukaemia cells and inhibits its tumour growth in nude mice Biochemical Pharmacology ·Julien Verrax, Julie Stockis, Aurélie Tison, Henryk Taper, Pedro Buc Calderón	2006	83
19	Role of glycolysis inhibition and poly(ADP‐ribose) polymerase activation in necrotic‐like cell death caused by ascorbate/menadione‐induced oxidative stress in K562 human chronic myelogenous leukemic cells International Journal of Cancer ·Julien Verrax, Stéphanie Vanbever, Julie Stockis, Henryk Taper, Pedro Buc Calderón	2006	48
20	The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy European Journal of Medicinal Chemistry ·Julien Verrax, Julie Cadrobbi, Marianne Delvaux, James M. Jamison, Jacques Gilloteaux, Jack L. Summers, Henryk Taper, Pedro Buc Calderón	2003	68

About Julien Verrax

Julien Verrax is a scholar working on Toxicology, Nutrition and Dietetics, Molecular Biology, Biophysics and Biochemistry, having authored 53 papers that have together received 5.0k indexed citations. Recurring topics across this work include Vitamin C and Antioxidants Research (24 papers), Bioactive Compounds and Antitumor Agents (12 papers), Coenzyme Q10 studies and effects (6 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Free Radicals and Antioxidants (5 papers), Retinoids in leukemia and cellular processes (5 papers), Heat shock proteins research (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (1.7k citations), Toxicology (334 citations), Nutrition and Dietetics (791 citations), Molecular Biology (3.1k citations) and Biochemistry (157 citations). Julien Verrax has collaborated with scholars based in Belgium, Chile and Brazil. Frequent co-authors include Pedro Buc Calderón, Olivier Féron, Bernard Gallez, Pierre Sonveaux, Christophe J. De Saedeleer, Brice Sid, Christophe Glorieux, Mark W. Dewhirst, Kelly M. Kennedy and Frédérique Végran. Their work appears in journals such as Biochemical Pharmacology, Free Radical Biology and Medicine, PLoS ONE, Biochemical and Biophysical Research Communications and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact